Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...
Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...
Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...
Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector. Lemonaid operates an on ...
Buying prescription drugs online is easier than ever. But there are side effects. Direct-to-consumer startups like Hims and Ro want you to bypass your doctor and buy prescription drugs directly ...
Over the past five years the OTV has added several high-profile digital health firms to its portfolio, including TytoCare, Lemonaid Health, Emedgene, Scopio, and Donisi Health. OTV was founded in ...
Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...
Download Sample Report PDF (Including Full TOC, Table & Figures) @ The Major Players Covered in this Report: Siemens Healthcare GmbH, Lifesize, LEMONAID HEALTH INC., Koninklijke Philips N.V., IBM ...
The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts.
The struggling health company bought virtual care startup Lemonaid in 2021 for $400 million. 23andMe's stock has plummeted after a 2023 data breach exposed millions of customer accounts. Struggling ...